Market Overview:
The global imipenem market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, growing demand for antibiotics, and rising investments by pharmaceutical companies in R&D activities. Based on type, the global imipenem market can be segmented into sterile type and non-sterile type. The sterile type segment is expected to account for a larger share of the global market than the non-sterile type segment during the forecast period. This can be attributed to factors such as growing demand for injectable drugs and rising incidence of hospital-acquired infections (HAIs). Based on application, the global imipenem market can be divided into injection and other applications.
Product Definition:
Imipenem is a beta-lactam antibiotic used to treat bacterial infections. It is often prescribed in combination with cilastatin, which inhibits the degradation of imipenem by renal tubular cells, allowing for higher serum levels and longer duration of action. Imipenem is important because it is effective against a wide range of bacteria, including resistant strains.
Sterile Type:
Imipenem is a synthetic antibiotic used to treat infections in the urinary tract, respiratory tract, and bloodstream. It works by killing the bacteria causing infection. The drug has been approved for use in treating urinary tract infections (UTIs) caused by Escherichia coli and Proteus mirabilis. UTIs are among the most common types of bacterial pneumonia and contribute significantly to community-acquired pneumonia rates worldwide.
Non-sterile Type:
Non-sterile type is a generic term used for packaging of pharmaceutical products. It is also known as white or opaque bottles or containers. Non-sterile type packaging includes glass and plastic bottles, metal cans, and others.
Application Insights:
Injection application dominated the global market with a revenue share of over 80% in 2017. The high penetration is attributed to the wide availability of healthcare facilities and efficient distribution channels that offer affordable prices for drugs. In addition, stable government policies and regulations have played a key role in promoting its use across various medical applications.
The other application segment includes oral tablets & capsules, topical creams & ointments, suppository powder pouches and liquid oral suspension among others. Oral tablets & capsules are expected to witness significant growth owing to their convenient usage along with minimal risk of drug resistance development at the site of infection as well as during systemic circulation after absorption by target organs such as kidneys, liver and lungs among others.
Regional Analysis:
North America dominated the global imipenem market in 2017. The presence of a large number of manufacturers coupled with high healthcare expenditure and favorable reimbursement policies are some factors attributing to its largest share. In addition, increasing incidence of infectious diseases is also expected to be one factor responsible for its largest share by 2030 as it has been observed that most common infectious diseases such as respiratory infections, skin infections, and digestive system infections are highly prevalent among North American population.
Asia Pacific is anticipated to witness the fastest growth over the forecast period owing to rising incidences of multi-drug resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB). According to WHO data published in May 2018, India reported 937 new cases of MDR TB out of which 468 cases were detected in Western Uttar Pradesh state alone during 2015 - 2016 while only 2% cases were detected in Europe during same year.
Growth Factors:
- Increasing incidence of hospital-acquired infections (HAIs) due to the increasing number of surgeries and other invasive procedures, growing population of elderly and immunocompromised patients, and rising prevalence of antibiotic-resistant pathogens.
- Rising demand for Imipenem owing to its broad-spectrum activity against a wide range of Gram-positive and Gram-negative bacteria, including multidrug resistant strains.
- Growing awareness about the benefits of early treatment with Imipenem over other antibiotics for reducing the risk of mortality and morbidity in patients with HAIs.
- Technological advancements in drug discovery that are resulting in the development of novel antibiotics such as carbapenems, which are effective against multi drug resistant pathogens.
Scope Of The Report
Report Attributes
Report Details
Report Title
Imipenem Market Research Report
By Type
Sterile Type, Non-sterile Type
By Application
Injection, Other
By Companies
Savior Lifetec, Sun Pharmaceutical Industries, Kopran, HISUN Pharmaceutical, Haibin Pharmaceutical, United Lab
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Imipenem Market Report Segments:
The global Imipenem market is segmented on the basis of:
Types
Sterile Type, Non-sterile Type
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Injection, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Savior Lifetec
- Sun Pharmaceutical Industries
- Kopran
- HISUN Pharmaceutical
- Haibin Pharmaceutical
- United Lab
Highlights of The Imipenem Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Sterile Type
- Non-sterile Type
- By Application:
- Injection
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Imipenem Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Imipenem is a broad-spectrum antibiotic that is used to treat a variety of infections, including pneumonia, sepsis, and acute respiratory distress syndrome (ARDS). Imipenem works by killing bacteria. It is usually given as an intravenous injection.
Some of the major players in the imipenem market are Savior Lifetec, Sun Pharmaceutical Industries, Kopran, HISUN Pharmaceutical, Haibin Pharmaceutical, United Lab.
The imipenem market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Imipenem Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Imipenem Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Imipenem Market - Supply Chain
4.5. Global Imipenem Market Forecast
4.5.1. Imipenem Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Imipenem Market Size (000 Units) and Y-o-Y Growth
4.5.3. Imipenem Market Absolute $ Opportunity
5. Global Imipenem Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Imipenem Market Size and Volume Forecast by Type
5.3.1. Sterile Type
5.3.2. Non-sterile Type
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Imipenem Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Imipenem Market Size and Volume Forecast by Application
6.3.1. Injection
6.3.2. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Imipenem Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Imipenem Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Imipenem Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Imipenem Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Imipenem Demand Share Forecast, 2019-2026
9. North America Imipenem Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Imipenem Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Imipenem Market Size and Volume Forecast by Application
9.4.1. Injection
9.4.2. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Imipenem Market Size and Volume Forecast by Type
9.7.1. Sterile Type
9.7.2. Non-sterile Type
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Imipenem Demand Share Forecast, 2019-2026
10. Latin America Imipenem Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Imipenem Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Imipenem Market Size and Volume Forecast by Application
10.4.1. Injection
10.4.2. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Imipenem Market Size and Volume Forecast by Type
10.7.1. Sterile Type
10.7.2. Non-sterile Type
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Imipenem Demand Share Forecast, 2019-2026
11. Europe Imipenem Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Imipenem Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Imipenem Market Size and Volume Forecast by Application
11.4.1. Injection
11.4.2. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Imipenem Market Size and Volume Forecast by Type
11.7.1. Sterile Type
11.7.2. Non-sterile Type
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Imipenem Demand Share, 2019-2026
12. Asia Pacific Imipenem Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Imipenem Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Imipenem Market Size and Volume Forecast by Application
12.4.1. Injection
12.4.2. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Imipenem Market Size and Volume Forecast by Type
12.7.1. Sterile Type
12.7.2. Non-sterile Type
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Imipenem Demand Share, 2019-2026
13. Middle East & Africa Imipenem Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Imipenem Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Imipenem Market Size and Volume Forecast by Application
13.4.1. Injection
13.4.2. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Imipenem Market Size and Volume Forecast by Type
13.7.1. Sterile Type
13.7.2. Non-sterile Type
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Imipenem Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Imipenem Market: Market Share Analysis
14.2. Imipenem Distributors and Customers
14.3. Imipenem Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Savior Lifetec
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sun Pharmaceutical Industries
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Kopran
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. HISUN Pharmaceutical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Haibin Pharmaceutical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. United Lab
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook